TY  - GEN
AU  - Ruggeri,M
AU  - Basile,M
AU  - Coretti,S
AU  - Drago,C
AU  - Cicchetti,A
TI  - Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy
SN  - 1179-1896
PY  - 2018///0529
KW  - Antiviral Agents
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Guanine
KW  - analogs & derivatives
KW  - Health Care Costs
KW  - statistics & numerical data
KW  - Hepatitis B, Chronic
KW  - drug therapy
KW  - Humans
KW  - Italy
KW  - epidemiology
KW  - Markov Chains
KW  - Quality-Adjusted Life Years
KW  - Tenofovir
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s40258-017-0311-4
ER  -